A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06318273 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06318273
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-08
- Primary completion
- 2027-05-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.